Siriuspoint Ltd (SPNT) — SEC Filings
Siriuspoint Ltd (SPNT) — 44 SEC filings. Latest: 8-K (May 7, 2026). Includes 25 8-K, 6 10-Q, 5 SC 13G/A.
View Siriuspoint Ltd on SEC EDGAR
Overview
Siriuspoint Ltd (SPNT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Mar 30, 2026: SiriusPoint Ltd. filed an 8-K on March 30, 2026, reporting a change in control of the registrant as of March 25, 2026. The filing includes a press release as an exhibit, but specific details regarding the nature of the change in control or any associated financial figures are not provided in the sum
Sentiment Summary
Across 44 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 41 neutral. The dominant filing sentiment for Siriuspoint Ltd is neutral.
Filing Type Overview
Siriuspoint Ltd (SPNT) has filed 25 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 2 SC 13D/A, 5 SC 13G/A, 1 8-K/A, 1 SC 13G with the SEC between Feb 2024 to May 2026.
Filings by Year
Recent SEC Filings (44)
Risk Profile
Risk Assessment: Of SPNT's 37 recent filings, 1 were flagged as high-risk, 22 as medium-risk, and 14 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $755.9M |
| Net Income | $86.8M |
| EPS | $0.74 |
| Debt-to-Equity | 0.31 |
| Cash Position | $582.4M |
| Operating Margin | N/A |
| Total Assets | $12,460.2M |
| Total Debt | $682.5M |
Key Executives
- Mr. Egan
- Mr. Malloy
- Mr. Sankaran
- Cheryl Li
- Patrick Winter
- Robert (Bob) Deutsch
- Andrew Robinson
- Michael J. Scharff
Industry Context
SiriusPoint operates in the global insurance and reinsurance market, a sector characterized by intense competition, cyclicality, and significant regulatory oversight. Key trends include increasing demand for specialized insurance products, the impact of climate change on catastrophe risk, and the ongoing digitalization of underwriting and claims processes. The industry is also navigating evolving capital requirements and the influence of alternative capital providers.
Top Tags
amendment (5) · financial-reporting (4) · management-change (4) · corporate-governance (4) · 10-Q (4) · 8-K (3) · regulatory-filing (3) · financial-obligation (3) · financials (3) · insurance (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net income available to common shareholders (Q3 2025) | $86.8M | Increased significantly from $4.5M in Q3 2024 |
| Net premiums earned (Q3 2025) | $647.7M | Up from $568.9M in Q3 2024, indicating strong top-line growth |
| ArmadaCorp Capital sale price | $250M | Strategic divestiture expected to generate a substantial gain |
| Expected pre-tax gain from Armada sale | $220M-$230M | Significant capital boost upon closing in Q4 2025 |
| Basic EPS (Q3 2025) | $0.74 | A substantial improvement from $0.03 in Q3 2024 |
| Net premiums earned (9 months ended Sep 30, 2025) | $1,926.4M | Increased from $1,753.2M in the prior year period |
| Loss and loss adjustment expense reserves (Sep 30, 2025) | $5,811.7M | Increased from $5,653.9M at Dec 31, 2024 |
| Total assets (Sep 30, 2025) | $12,460.2M | Slight decrease from $12,524.9M at Dec 31, 2024 |
| Common shares outstanding (Oct 29, 2025) | 116,814,640 | Reflects the current share count |
| Total revenues (Q3 2025) | $755.9M | Up from $562.2M in Q3 2024, driven by premium growth and absence of prior year's loss |
| Net Loss | $10.0M | Q2 2025, compared to $25.0M net income in Q2 2024 |
| Total Revenues | $550.0M | Q2 2025, an 8% decrease from $600.0M in Q2 2024 |
| Common Shares Outstanding | 150.0M | As of June 30, 2025, stable year-over-year |
| Series B Preferred Stock Outstanding | 5.0M | As of June 30, 2025 |
| Reporting Period End Date | 2025-03-31 | Indicates the end of the financial quarter being reported. |
Forward-Looking Statements
- {"claim":"Capital Research Global Investors will maintain a significant stake in SiriusPoint Ltd. for the foreseeable future.","entity":"Capital Research Global Investors","targetDate":"2025-12-31","confidence":"medium"}
- {"claim":"SiriusPoint Ltd.'s stock price may experience increased stability due to the large institutional holding.","entity":"SiriusPoint Ltd.","targetDate":"2024-08-09","confidence":"low"}
- {"claim":"Other institutional investors may take a closer look at SiriusPoint Ltd following Wellington Management's disclosure.","entity":"SiriusPoint Ltd","targetDate":"Q2 2024","confidence":"medium"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Siriuspoint Ltd (SPNT)?
Siriuspoint Ltd has 44 recent SEC filings from Feb 2024 to May 2026, including 25 8-K, 6 10-Q, 5 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of SPNT filings?
Across 44 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 41 neutral. The dominant sentiment is neutral.
Where can I find Siriuspoint Ltd SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Siriuspoint Ltd (SPNT) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Siriuspoint Ltd?
Key financial highlights from Siriuspoint Ltd's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for SPNT?
The investment thesis for SPNT includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Siriuspoint Ltd?
Key executives identified across Siriuspoint Ltd's filings include Mr. Egan, Mr. Malloy, Mr. Sankaran, Cheryl Li, Patrick Winter and 3 others.
What are the main risk factors for Siriuspoint Ltd stock?
Of SPNT's 37 assessed filings, 1 were flagged high-risk, 22 medium-risk, and 14 low-risk.
What are recent predictions and forward guidance from Siriuspoint Ltd?
Recent forward-looking statements from Siriuspoint Ltd include guidance on {"claim":"Capital Research Global Investors will maintain a significant stake in SiriusPoint Ltd. for the foreseeable fu and 2 other predictions.